Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · IEX Real-Time Price · USD
12.15
+0.24 (2.02%)
At close: Apr 19, 2024, 4:00 PM
12.19
+0.04 (0.33%)
After-hours: Apr 19, 2024, 4:05 PM EDT
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $408.25 million as of April 19, 2024. Its market cap has decreased by -21.69% in one year.
Market Cap
408.25M
Enterprise Value
120.56M
1-Year Change
-21.69%
Ranking
Category
Stock Price
$12.15
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $597.75M to $408.25M, a decrease of -31.70%. That is a compound annual growth rate of -14.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 400.20M | -2.53% |
Apr 17, 2024 | 410.60M | -3.93% |
Apr 16, 2024 | 427.40M | -1.32% |
Apr 15, 2024 | 433.10M | -0.46% |
Apr 12, 2024 | 435.10M | -2.36% |
Apr 11, 2024 | 445.60M | 5.92% |
Apr 10, 2024 | 420.70M | -5.71% |
Apr 9, 2024 | 446.20M | -1.26% |
Apr 8, 2024 | 451.90M | -2.61% |
Apr 5, 2024 | 464.00M | -0.15% |
Apr 4, 2024 | 464.70M | 0.15% |
Apr 3, 2024 | 464.00M | -0.51% |
Apr 2, 2024 | 466.40M | 0.87% |
Apr 1, 2024 | 462.40M | -2.88% |
Mar 28, 2024 | 476.10M | -1.27% |
Mar 27, 2024 | 482.20M | 4.28% |
Mar 26, 2024 | 462.40M | 2.85% |
Mar 25, 2024 | 449.60M | -2.47% |
Mar 22, 2024 | 461.00M | 1.32% |
Mar 21, 2024 | 455.00M | 1.43% |
Mar 20, 2024 | 448.60M | 5.13% |
Mar 19, 2024 | 426.70M | 2.33% |
Mar 18, 2024 | 417.00M | -2.89% |
Mar 15, 2024 | 429.40M | 4.76% |
Mar 14, 2024 | 409.90M | -4.03% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aquestive Therapeutics | 404.86M |
MaxCyte | 404.02M |
Mersana Therapeutics | 402.74M |
Tourmaline Bio | 401.62M |
Lexicon Pharmaceuticals | 401.37M |
Lexeo Therapeutics | 397.68M |
NeuroPace | 396.82M |
Biomea Fusion | 395.08M |